The U.K. signaled it wants more guarantees from Pfizer, the U.S. drugmaker seeking to acquire AstraZeneca, and held open the possibility of blocking the deal using a “public interest” defense. Bloomberg’s Caroline Hyde reports on Bloomberg Television’s “Bloomberg Surveillance.”